PD-1/PD-L1 inhibitors

Compounds according to formula (I), methods of using said compounds singly or in combination with additional agents and compositions of said compounds for the treatment of cancer are disclosed.

Saved in:
Bibliographic Details
Main Authors Graupe, Michael, Machicao Tello, Paulo A, Guerrero, Juan A, Venkataramani, Chandrasekar, Jabri, Salman Y, Du, Zhimin, Xu, Jie, Squires, Neil H, Aktoudianakis, Evangelos, Watkins, William J, Naduthambi, Devan, Yang, Kin Shing, Parkhill, Eric Q, Appleby, Todd, Ziebenhaus, Christopher Allen, Metobo, Samuel E, Simonovich, Scott Preston, Notte, Greggory, Wang, Peiyuan, Mukherjee, Prasenjit Kumar, Lad, Lateshkumar Thakorlal, Cho, Aesop, Phillips, Barton W, Medley, Jonathan William
Format Patent
LanguageEnglish
Published 02.02.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Compounds according to formula (I), methods of using said compounds singly or in combination with additional agents and compositions of said compounds for the treatment of cancer are disclosed.
Bibliography:Application Number: AU20220279537